刊名:Biochemical and Biophysical Research Communications
出版年:2017
出版时间:22 January 2017
年:2017
卷:482
期:4
页码:1259-1264
全文大小:888 K
卷排序:482
文摘
Ribavirin effectively targets OTSCC in vitro and in vivo. Ribavirin acts synergistically with paclitaxel in OTSCC cells. Ribavirin inhibits Akt/mTOR/eIF4E signaling in OTSCC. eIF4E inhibition sensitizes OTSCC cell response to paclitaxel.